These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 2881546)

  • 1. REV 2871 (CHBZ): a potent antiallergic agent with a novel mechanism of action. II. Studies on the mechanism of action.
    Coutts SM; Khandwala A; Weinryb I
    Biochem Pharmacol; 1987 Mar; 36(5):673-82. PubMed ID: 2881546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. REV 2871 (CHBZ): a potent antiallergic agent with a novel mechanism of action. I. Activity profile as an inhibitor of mediator release.
    Khandwala A; Coutts S; Pruss T; Jones H; Neiss E; Weinryb I
    Biochem Pharmacol; 1987 Mar; 36(5):663-72. PubMed ID: 2435293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. REV 2871 (CHBZ): a novel inhibitor of histamine release.
    Coutts SM; Khandwala A; Shoupe TS; Musser JH; Klunk LJ; Weinryb I
    Agents Actions; 1986 Jun; 18(3-4):318-24. PubMed ID: 2428220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RHC 3024: antiallergic activity in vitro and comparison with disodium cromoglycate and other antiallergic agents.
    Khandwala A; Coutts SM; Dally-Meade V; Jariwala N; Huang FC
    Int Arch Allergy Appl Immunol; 1983; 70(4):311-20. PubMed ID: 6186610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of rat peritoneal mast cell exocytosis by frusemide: a comparison with disodium cromoglycate.
    Stenton GR; Chow SM; Lau HY
    Life Sci; 1998; 62(3):PL49-54. PubMed ID: 9488107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiallergic activity of nylidrin hydrochloride (RHC 3432-A). I. Effect on release of histamine in vitro from rat peritoneal mast cells, guinea pig lung slices and human basophils.
    Khandwala A; Coutts SM; Weinryb I
    Int Arch Allergy Appl Immunol; 1983; 70(4):295-302. PubMed ID: 6186608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement by reproterol of the ability of disodium cromoglycate to stabilize rat mastocytes.
    Eleno N; Gajate E; Macias J; Garay RP
    Pulm Pharmacol Ther; 1999; 12(1):55-60. PubMed ID: 10208836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The protective effect of a new antiallergic agent, KP-136 on mast cell activation: a comparison with disodium cromoglycate.
    Kuriyama K; Hiyama Y; Ito K; Yoshinaka I; Bito Y
    Agents Actions; 1988 Dec; 25(3-4):321-5. PubMed ID: 3146215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of SA-103 on experimental allergic models in vivo and in vitro--comparison with disodium cromoglycate.
    Nabe T; Yamamura H; Kohno S; Ohata K
    Arerugi; 1992 Jun; 41(6):676-85. PubMed ID: 1280084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current views of the mechanism of action of prophylactic antiallergic drugs.
    González Alvarez R; Arruzazabala ML
    Allergol Immunopathol (Madr); 1981; 9(6):501-8. PubMed ID: 6122370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo immunopharmacologic properties of a new antiallergic agent RHC 3414.
    Khandwala A; Sonnino-Goldman P; Leibowitz M; Dally-Meade V; Donigi-Ruzza D
    Arch Int Pharmacodyn Ther; 1984 Jan; 267(1):103-22. PubMed ID: 6202252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RHC 3288 [1-methyl-2(1,3,4-oxadiazol-2(3H)-one-5-yl) benzimidazole] and related compounds. Novel inhibitors of histamine release from rat mast cells and human basophils.
    Khandwala A; Coutts S; Dally-Meade V; Jariwala N; Musser J; Brown R; Jones H; Loev B; Weinryb I
    Biochem Pharmacol; 1983 Nov; 32(22):3325-33. PubMed ID: 6197075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of disodium cromoglycate on mast cell-mediated immediate-type allergic reactions.
    Shin HY; Kim JS; An NH; Park RK; Kim HM
    Life Sci; 2004 Apr; 74(23):2877-87. PubMed ID: 15050425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiallergic action of disodium cromoglycate and xanthone RS 7540.
    Gonzalez Alvarez R; Kazimierczak W
    Arch Immunol Ther Exp (Warsz); 1982; 30(5-6):333-9. PubMed ID: 6135406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A binding site on mast cells and basophils for the anti-allergic drug cromolyn.
    Mazurek N; Berger G; Pecht I
    Nature; 1980 Aug; 286(5774):722-3. PubMed ID: 6157990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cromoglycate on anaphylactic histamine release from rat peritoneal mast cells.
    Garland LG
    Br J Pharmacol; 1973 Sep; 49(1):128-30. PubMed ID: 4132518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of cromolyn-induced phosphorylation of a 78-kDa protein by phorbol esters in rat peritoneal mast cells.
    Cox A; Law NM; Findlay JB
    Biochem Pharmacol; 1998 Mar; 55(5):585-94. PubMed ID: 9515569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel cell-permeable cromoglycate derivative inhibits type I Fc epsilon receptor mediated Ca2+ influx and mediator secretion in rat mucosal mast cells.
    Hemmerich S; Sijpkens D; Pecht I
    Biochemistry; 1991 Feb; 30(6):1523-32. PubMed ID: 1704255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the anti-anaphylactic activities of salbutamol and disodium cromoglycate in the rat, the rat mast cell and in human lung tissue.
    Butchers PR; Fullarton JR; Skidmore IF; Thompson LE; Vardey CJ; Wheeldon A
    Br J Pharmacol; 1979 Sep; 67(1):23-32. PubMed ID: 115530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organophosphate-induced histamine release from mast cells.
    Newball HH; Donlon MA; Procell LR; Helgeson EA; Franz DR
    J Pharmacol Exp Ther; 1986 Sep; 238(3):839-45. PubMed ID: 2427688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.